Method for loading solid supports for nucleic acid synthesis

• US 5,554,744 A
• Filed: 09/23/1994
• Issued: 09/10/1996
• Est. Priority Date: 09/23/1994
• Status: Expired due to Fees

• Current Assignee: Nitto Denko Avecia, Inc. (Nitto Denko Corporation)
• Original Assignee: Hybridon, Inc. (Aceragen Incorporated)
• Inventors: Bhongle, Nandkumar, Tang, Jin-Yan
• Primary Examiner(s): Rollins, John W.
• Application Number:
  US08/311,156
• Time in Patent Office: 718 Days
• Field of Search: 536/22.1, 536/25.3
• US Class Current: 536/25.3
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Abstract

New methods of loading solid supports for oligonucleotide synthesis are presented. The new methods comprise coupling a succinylated nucleoside to a solid support using diisopropylcarbodiimide (DIC) as an activator and N-hydroxybenzotriazole (HOBT) as an acid catalyst. DIC is substantially cheaper than the currently used activating agent, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (DEC). Furthermore, in the preferred embodiment, when it is used in combination with HOBT, coupling is more efficient, requiring less nucleoside to achieve the same loading densities as in the prior art. The loading process is faster than prior art methods and the overall cost savings of about 43% are realized.

Claims

1. A method of loading a functionalized solid support for oligonucleotide synthesis comprising simultaneously contacting in a solvent the functionalized solid support with diisopropylcarbodiimide, a nucleoside having a 3'"'"' linker group attached, and an acid catalyst.

2. The method of claim 1 wherein the acid catalyst is N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or a combination thereof.

3. The method of claim 2 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

4. The method of claim 3 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

5. The method of claim 4 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 times that of the diisopropylcarbodiimide.

6. The method of claim 2 wherein the solvent comprises about 5% or less pyridine.

7. The method of claim 6 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

8. The method of claim 7 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

9. The method of claim 8 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 that of the diisopropylcarbodiimide.

10. The method of claim 2 wherein the solvent contains no pyridine.

11. The method of claim 10 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

12. The method of claim 11 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

13. The method of claim 12 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 that of the diisopropylcarbodiimide.

14. A method of loading a functionalized solid support for oligonucleotide synthesis comprising simultaneously contacting in a solvent a functionalized solid support having a linker moiety with diisopropylcarbodiimide, a nucleoside having a free 3'"'"' hydroxy group, and an acid catalyst.

15. The method of claim 14 wherein the acid catalyst is N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or a combination thereof.

16. The method of claim 15 wherein the functionalized solid support is CPG.

17. The method of claim 16 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

18. The method of claim 17 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

19. The method of claim 18 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 times that of the diisopropylcarbodiimide.

20. The method of claim 15 wherein the solvent comprises about 5% or less pyridine.

21. The method of claim 20 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

22. The method of claim 21 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

23. The method of claim 22 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 that of the diisopropylcarbodiimide.

24. The method of claim 15 wherein the solvent contains no pyridine.

25. The method of claim 24 wherein the solid support is CPG and less than about 3×

10^-3 mol of nucleoside is used per 25 g of CPG.

26. The method of claim 25 wherein about 2 to about 3 moles of diisopropylcarbodiimide are used per mole of nucleoside.

27. The method of claim 26 wherein the amount of N-hydroxybenzotriazole or nitrohydroxybenzotriazole, or combination thereof is about 0.1 that of the diisopropylcarbodiimide.